Literature DB >> 29750244

Regulation of Hepatic Lipid Accumulation and Distribution by Agouti-Related Protein in Male Mice.

Matthew T Maier1, Anna Vilhelmsson1, Sharon M Louie2,3,4, Eirini Vagena1, Daniel K Nomura2,3,4, Suneil K Koliwad1,5, Allison W Xu1,6.   

Abstract

Proper regulation of energy metabolism requires neurons in the central nervous system to respond dynamically to signals that reflect the body's energy reserve, and one such signal is leptin. Agouti-related protein (AgRP) is a hypothalamic neuropeptide that is markedly upregulated in leptin deficiency, a condition that is associated with severe obesity, diabetes, and hepatic steatosis. Because deleting AgRP in mice does not alter energy balance, we sought to determine whether AgRP plays an indispensable role in regulating energy and hepatic lipid metabolism in the sensitized background of leptin deficiency. We generated male mice that are deficient for both leptin and AgRP [double-knockout (DKO)]. DKO mice and ob/ob littermates had similar body weights, food intake, energy expenditure, and plasma insulin levels, although DKO mice surprisingly developed heightened hyperglycemia with advancing age. Overall hepatic lipid content was reduced in young prediabetic DKO mice, but not in the older diabetic counterparts. Intriguingly, however, both young and older DKO mice had an altered zonal distribution of hepatic lipids with reduced periportal lipid deposition. Moreover, leptin stimulated, whereas AgRP inhibited, hepatic sympathetic activity. Ablating sympathetic nerves to the liver, which primarily innervate the portal regions, produced periportal lipid accumulation in wild-type mice. Collectively, our results highlight AgRP as a regulator of hepatic sympathetic activity and metabolic zonation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29750244      PMCID: PMC6692877          DOI: 10.1210/en.2018-00040

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Plasma Agouti-Related Protein Levels in Acromegaly and Effects of Surgical or Pegvisomant Therapy.

Authors:  Pamela U Freda; Carlos Reyes-Vidal; Zhezhen Jin; Mya Pugh; Sunil K Panigrahi; Jeffrey N Bruce; Sharon L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

2.  Multi-Trait Genome-Wide Association Study of Atherosclerosis Detects Novel Pleiotropic Loci.

Authors:  Tiffany R Bellomo; William P Bone; Brian Y Chen; Katerina A B Gawronski; David Zhang; Joseph Park; Michael Levin; Noah Tsao; Derek Klarin; Julie Lynch; Themistocles L Assimes; J Michael Gaziano; Peter W Wilson; Kelly Cho; Marijana Vujkovic; Christopher J O'Donnell; Kyong-Mi Chang; Philip S Tsao; Daniel J Rader; Marylyn D Ritchie; Scott M Damrauer; Benjamin F Voight
Journal:  Front Genet       Date:  2022-02-02       Impact factor: 4.772

3.  The acromegaly lipodystrophy.

Authors:  Pamela U Freda
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

4.  Neuronal modulation of hepatic lipid accumulation induced by bingelike drinking.

Authors:  Maria Ibars; Matthew T Maier; Ernie Yulyaningsih; Luz Perez; Rachel Cheang; Anna Vilhelmsson; Sharon M Louie; Scott A Wegner; Xiaoyi Yuan; Holger K Eltzschig; Frederic W Hopf; Daniel K Nomura; Suneil K Koliwad; Allison W Xu
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-02-11       Impact factor: 5.900

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.